Home » ASPREVA PHARMACEUTICALS ADDED TO THE NASDAQ BIOTECHNOLOGY INDEX
ASPREVA PHARMACEUTICALS ADDED TO THE NASDAQ BIOTECHNOLOGY INDEX
Aspreva Pharmaceuticals Corporation, an emerging pharmaceutical company focused on increasing the pool of evidence-based medicines available for patients with less common diseases, announced that effective today, the Company has been added to the NASDAQ Biotechnology Index.
PR Newswire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May